The UK has approved its first weight-loss tablet containing semaglutide, giving patients a needle-free alternative to popular injectable treatments such as Wegovy and Ozempic.
The Medicines and Healthcare products Regulatory Agency (MHRA) authorised the oral version of Wegovy on 11 June, making the UK the first country in Europe to approve this treatment.